Company · CIK 2075320

# Polaryx Therapeutics, Inc.

| CIK | [2075320](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002075320) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | WY |
| Business address | NJ |
| Listed | PLYX (Nasdaq) |
| First annual or quarterly report | 2026-03-24 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-291681 | IPO Final prospectus | 2025-11-21 | 2026-02-02 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-02-02 | [424B4](https://www.sec.gov/Archives/edgar/data/2075320/000121390026010761/0001213900-26-010761-index.htm) Final prospectus | 333-291681 | 0001213900-26-010761 |
| 2026-01-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2075320/999999999526000339/9999999995-26-000339-index.htm) Declared effective | 333-291681 | 9999999995-26-000339 |
| 2026-01-27 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2075320/000121390026007973/0001213900-26-007973-index.htm) Amendment | 333-291681 | 0001213900-26-007973 |
| 2026-01-14 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2075320/000121390026004079/0001213900-26-004079-index.htm) Amendment | 333-291681 | 0001213900-26-004079 |
| 2025-11-21 | [S-1](https://www.sec.gov/Archives/edgar/data/2075320/000121390025113249/0001213900-25-113249-index.htm) Registration filed | 333-291681 | 0001213900-25-113249 |
| 2025-08-05 | [DRS](https://www.sec.gov/Archives/edgar/data/2075320/000121390025072048/0001213900-25-072048-index.htm) Draft made public | 377-08292 | 0001213900-25-072048 |

[All filings of this company](https://equitycapital.markets/filings?cik=2075320) · [CSV](https://equitycapital.markets/filings.csv?cik=2075320)

---
Source page: https://equitycapital.markets/company/2075320 · Data: U.S. SEC EDGAR · CC BY 4.0